Fig. 1
Total-body dual-isotope PET/MR imaging using [11C]acetate and [18F]FDG in the KrasG12D/+, p53−/− mouse model of lung cancer. (A) Transversal PET/MRI images for three different tumours—PET images were acquired early between 10 and 20 min post-injection, late between 80 and 100 min post-injection for [11C]acetate and late for [18F]FDG. Tumours T1, T2 and T3 are arrowed, and H indicates the heart. (B) Time activity curves for [11C]acetate and [18F]FDG in the tumours and a muscle. Windows of optimal acquisition time are highlighted for the early and late imaging with [11C]acetate and [18F]FDG.